bayer ag fda approves drug nexavar for treatment of liver cancer germany based bayer ag said its drug nexavar has been approved in the u s for the treatment of liver cancer the food and drug administration extended the approval of the oral drug for the treatment of patients with the most common sort of liver cancer bayer said the drug had already been approved in europe for the treatment of liver cancer and it has been approved since for the treatment of advanced kidney cancer in more than countries including the u s the move "will likely establish nexavar as the standard systemic therapy for the treatment of liver cancer and is a turning point in improving treatment outcomes in patients facing the devastating impact of this disease " according to arthur higgins chairman of bayer healthcare ag 
